Thickness of Retinal Layers in Amblyopia
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to examine retinal layer thickness in amblyopia.
| Condition | Intervention |
|---|---|
|
Amblyopia |
Other: Optical coherence tomography |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Analysis of Spectral Domain Optical Coherence Tomography Measurements in Amblyopia |
- Retinal layer thickness [ Time Frame: One month ] [ Designated as safety issue: No ]Optical coherence tomography scan will be conducted to analyze retinal layer thickness, when the patient are enrolled.
| Enrollment: | 22 |
| Study Start Date: | April 2010 |
| Study Completion Date: | June 2010 |
| Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
Retinal layer thickness analysis
Optical coherence tomography will be conducted to analyze retinal layer thickness (safe examination)
|
Other: Optical coherence tomography
Spectral domain optical coherence tomography will be conducted once when patients are enrolled.
Other Name: Spectralis Optical coherence tomography
|
Detailed Description:
Amblyopia is a visual disorder characterized by a reduction of vision that cannot be immediately improved by refractive correction or accounted for by clinically determined anatomic defects of the eye or visual pathway. Evidence for direct retinal changes in eyes with amblyopia has been controversial. It has been hypothesized that amblyopia may affect the postnatal maturation of the retina including the postnatal reduction of retinal ganglion cells. However, although some studies have found incrased retinal nerve fiber layer thickness in amblyopic eyes, others have found no significant differences. This sutdy will examine the retinal layer thickness in amblyopia and compare the retinal layer thickness between amblyopic eyes and nonamblyopic fellow eyes.
Eligibility| Ages Eligible for Study: | 4 Years to 19 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
patients in tertiary hospital
Inclusion Criteria:
- Amblyopia
Exclusion Criteria:
- Other retinal disease
- Anisometropia
- Neurologic abnormalities
Contacts and Locations
More Information
Publications:
| Responsible Party: | Se Yeul Oh, M.D., Samsung Medical Center |
| ClinicalTrials.gov Identifier: | NCT01179763 History of Changes |
| Other Study ID Numbers: | 2009-12-089 |
| Study First Received: | August 5, 2010 |
| Last Updated: | August 10, 2010 |
| Health Authority: | Korea: Institutional Review Board |
Keywords provided by Samsung Medical Center:
|
Amblyopia Retinal layer thickness |
Additional relevant MeSH terms:
|
Amblyopia Brain Diseases Central Nervous System Diseases Nervous System Diseases Vision Disorders |
Sensation Disorders Neurologic Manifestations Eye Diseases Signs and Symptoms |
ClinicalTrials.gov processed this record on May 19, 2013